Product Categories
| Country: | United States |
|---|---|
| Tel: | +1-781-999-5354 |
| Mobile: | +17819995354 |
| E-mail: | marketing@targetmol.com |
| QQ: | |
| Skype: | Chat Now! |
| Address: | 36?Washington?Street, Wellesley?Hills |
|
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
|
|
| Product Name | MF | CAS | Details |
|---|
| Btk inhibitor 2 | C24H25N5O3 | 1558036-85-3 | Details |
| Bucindolol | C22H25N3O2 | 71119-11-4 | Details |
| Bunaftide | C21H30N2O | 32421-46-8 | Details |
| Norepinephrine bitartrate monohydrate | C12H17NO9 | 108341-18-0 | Details |
| IBT6A hydrochloride | C22H23ClN6O | 1553977-42-6 | Details |
| (Rac)-IBT6A | C22H22N6O | 1412418-47-3 | Details |
| Capsaicin；8-Methyl-N-vanillyl-trans-6-nonenamide;Qutenza;Zostrix;(E)-Capsaicin;Vanilloid | C18H27NO3 | 404-86-4 | Details |
| Bromelain | N/A | 9001-00-7 | Details |
| Ticarcillin disodium | C15H17N2NaO6S2 | 4697-14-7 | Details |
| BY27 | C22H21ClN6 | 2247236-59-3 | Details |
| BuChE-IN-TM-10 | C32H38N2O3 | 2313524-95-5 | Details |
| Burixafor hydrobromide；TG-0054 hydrobromide | C27H52BrN8O3P | 1191450-19-7 | Details |
| BSc5371 | C24H31N5O4S | 2286419-03-0 | Details |
| Bucolome；Paramidin;Paramidine | C14H22N2O3 | 841-73-6 | Details |
| Broflanilide | C25H14BrF11N2O2 | 1207727-04-5 | Details |
| BTK inhibitor 10 | C25H23N5O3 | 2241732-30-7 | Details |
| Bumetanide-d5；Bumetanide D5 | C17H20N2O5S | 1216739-35-3 | Details |
| IBT6A | C22H22N6O | 1022150-12-4 | Details |
| BT-13 | C23H27F4N3O4S | 924537-98-4 | Details |
| Bromodomain IN-1 | C22H23ClN4O3S | 1914120-48-1 | Details |
| Bromodomain inhibitor-8 | C26H25ClN2O3 | 1300031-70-2 | Details |
| BTK inhibitor 13 | C29H26FN5O3 | 2376726-26-8 | Details |
| C-11 | C38H58N6O7S | 2007965-97-9 | Details |
| C-82 | C33H34N6O4 | 1422253-37-9 | Details |
| c-di-AMP；Cyclic diadenylate;Cyclic-di-AMP | C20H24N10O12P2 | 54447-84-6 | Details |
| c-Fms-IN-1 | C22H27N5O2 | 885703-64-0 | Details |
| c-Fms-IN-9 | C21H23N7O2 | 1628574-50-4 | Details |
| c-Fms-IN-8 | C27H30N2O5 | 1255303-58-2 | Details |
| c-Fms-IN-7 | C26H24N6OS | 1313408-89-7 | Details |
| c-Fms-IN-6 | C22H25N7O2 | 1628574-81-1 | Details |
| c-Fms-IN-10 | C22H19N7OS | 1527517-50-5 | Details |
| C-021 dihydrochloride | C27H42ClN5O2 | 1784252-84-1 | Details |
| Butin | C15H12O5 | 21913-99-5 | Details |
| 5α-reductase-IN-1 | C31H37NO5 | 119348-12-8 | Details |
| Camalexin | C11H8N2S | 135531-86-1 | Details |
| Calmidazolium chloride | C31H23Cl7N2O | 57265-65-3 | Details |
| Canagliflozin-d4；Canagliflozin D4 | C24H25FO5S | 1997338-61-0 | Details |
| Calhex 231 hydrochloride | C25H28Cl2N2O | 2387505-78-2 | Details |
| c-Fms-IN-3 | C23H30N6O | 885704-21-2 | Details |
| Calcimycin | C29H37N3O6 | 52665-69-7 | Details |
| Candesartan-d4；CV-11974 D4;Candesartan D4 | C24H16D4N6O3 | 1346604-70-3 | Details |
| Capzimin | C30H24N6O2S4 | 2084868-04-0 | Details |
| Ca2+ channel agonist 1 | C19H26N6O | 1402821-24-2 | Details |
| CAL-130 | C23H22N8O | 1431697-74-3 | Details |
| Calcium-Sensing Receptor Antagonists I | C23H24N2O2 | 478963-79-0 | Details |
| Candoxatril | C29H41NO7 | 123122-55-4 | Details |
| Potassium Channel Activator 1 | C19H23N3O3 | 908608-06-0 | Details |
| c-met-IN-1 | C35H37FN6O5 | 2084836-84-8 | Details |
| CA inhibitor 1；GS-6207 analog | C41H36ClF8N7O5S2 | 2189684-45-3 | Details |
| Baclofen | C10H12ClNO2 | 1134-47-0 | Details |
| CAL-130 Hydrochloride | C23H23ClN8O | 1431697-78-7 | Details |
| CAL-130 Racemate | C23H22N8O | 474012-90-3 | Details |
| Calcimycin hemicalcium salt；A-23187 hemicalcium salt;Antibiotic A-23187 hemicalcium salt | C58H72CaN6O12 | 59450-89-4 | Details |
| Calcifediol-D6 | C27H44O2 | 78782-98-6 | Details |
| Amphotericin B | C47H73NO17 | 1397-89-3 | Details |
| Carbodenafil | C24H32N6O3 | 944241-52-5 | Details |
| Carbodine | C10H15N3O4 | 71184-20-8 | Details |
| Carebastine | C32H37NO4 | 90729-42-3 | Details |
| Carcainium chloride | C18H22ClN3O2 | 1042-42-8 | Details |
| Carboxypeptidase G2 (CPG2) Inhibitor | C13H15NO6S | 192203-60-4 | Details |
| Carbacyclin；Carbaprostacyclin;Carba-PGI2 | C21H34O4 | 69552-46-1 | Details |
| Ketanserin | C22H22FN3O3 | 74050-98-9 | Details |
| C75 | C14H22O4 | 218137-86-1 | Details |
| c-Met inhibitor 1 | C17H14N8S | 1357072-61-7 | Details |
| trans-C75；(±)-C75 | C14H22O4 | 191282-48-1 | Details |
| c-Met-IN-2 | C24H21FN10O | 1635406-73-3 | Details |
| Vimseltinib | C23H25N7O2 | 1628606-05-2 | Details |
| c-Kit-IN-3 | C26H20ClF3N2O4 | 2363169-01-9 | Details |
| c-Kit-IN-2 | C25H29N9O2S | 2121515-37-3 | Details |
| Calcium 2-oxoglutarate | C5H8CaO5 | 71686-01-6 | Details |
| Calcitriol-d6；Calcitriol D6 | C27H38D6O3 | 78782-99-7 | Details |
| MEK-IN-1 | C24H20N4O4 | 870600-45-6 | Details |
| Dithranol | C14H10O3 | 1143-38-0 | Details |
| CARM1-IN-1 | C26H21Br2NO3 | 1020399-49-8 | Details |
| Cav 2.2 blocker 1 | C25H29ClN2O2 | 1567335-29-8 | Details |
| Casopitant mesylate；GW679769B | C31H39F7N4O5S | 414910-30-8 | Details |
| CAY10595 | C20H13Cl2FN2O5 | 916047-16-0 | Details |
| Metoclopramide hydrochloride | C14H23Cl2N3O2 | 7232-21-5 | Details |
| Cauloside D | C53H86O22 | 12672-45-6 | Details |
| CB-6644 | C29H34ClFN4O5 | 2316817-88-4 | Details |
| Numidargistat；INCB01158;CB-1158 | C11H22BN3O5 | 2095732-06-0 | Details |
| Casein Kinase II Inhibitor IV | C24H23N5O3 | 863598-09-8 | Details |
| Carvedilol metabolite 4-Hydroxyphenyl Carvedilol；4-Hydroxyphenyl Carvedilol;4-Hydroxycarvedilol | C24H26N2O5 | 142227-49-4 | Details |
| Carpaine | C28H50N2O4 | 3463-92-1 | Details |
| Carpaine hydrochloride | C28H51ClN2O4 | 5853-21-4 | Details |
| (+)-CBI-CDPI2 | C36H28N6O4 | 128300-15-2 | Details |
| CCG 203769 | C8H14N2O2S | 410074-60-1 | Details |
| (+)-CBI-CDPI1 | C25H20N4O3 | 128300-14-1 | Details |
| CB2 modulator 1 | C18H19F3N4O2 | 666261-80-9 | Details |
| Cefmetazole sodium | C15H18N7NaO5S3 | 56796-39-5 | Details |
| CCI-006 | C15H12N2O5S | 292053-42-0 | Details |
| CBB1003 | C25H31N9O4 | 1379573-88-2 | Details |
| CCB02 | C14H9N3O | 2100864-57-9 | Details |
| Mezigdomide | C32H30FN5O4 | 2259648-80-9 | Details |
| CBB1007 | C27H34N8O4 | 1379573-92-8 | Details |
| CBP/p300-IN-2；CBP/EP300-IN-2 | C27H29F2N7O2 | 2158265-96-2 | Details |
| Carmoxirole hydrochloride | C24H26N2O2.ClH | 115092-85-8 | Details |
| CB1151 | C28H46O4 | 182369-28-4 | Details |
| CB1 inverse agonist 1 | C25H18Cl3N3O3 | 852315-00-5 | Details |
| CB2R-IN-1 | C23H27F3N4O6S3 | 1257555-79-5 | Details |
| Product Total： Product Page： | ||||
| 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 | ||||